Jump to content

Michael McGuinness

The neutral encyclopedia of notable people
Michael McGuinness
NationalityAmerican
OccupationAcademic, researcher
Known forInterdisciplinary research publications

Michael McGuinness is an academic affiliated with Saint Anselm College whose name appears across a broad and varied body of published research indexed on Semantic Scholar. The scope of the work attributed to this name spans clinical medicine, oncology, nutrition science, agricultural technology, and information systems, reflecting a publication record that, according to available bibliometric data, includes 132 papers and 428 total citations, yielding an h-index of 11.[1]

Education

Detailed information regarding the formal educational background of Michael McGuinness, including undergraduate and graduate institutions, degrees conferred, and dates of study, is not available in the source material reviewed for this article. Public academic and bibliometric records consulted did not contain specific biographical details pertaining to his schooling prior to his professional and research activity.[2]

Career

Michael McGuinness is listed as affiliated with Saint Anselm College.[3] Beyond this institutional affiliation, comprehensive career details such as prior appointments, promotions, or administrative roles are not documented in the available data bundle. The breadth of subject matter found under his name in bibliographic databases, ranging from diabetes management and trauma resuscitation to agricultural marketplace platforms and cancer drug discovery, suggests either a wide-ranging interdisciplinary research portfolio or the aggregation of works from multiple contributors sharing the same name within citation indexing systems. No further clarifying career narrative is available in the source material.[4]

Research

The published record associated with Michael McGuinness, as catalogued by Semantic Scholar, covers several distinct research domains.

Clinical and metabolic medicine

Among the works associated with this name is a 2026 study titled "Real-world insights on cardiometabolic, glycemic, and safety outcomes of dapagliflozin-based therapy in patients with type 2 diabetes," published in the World Journal of Advanced Research and Reviews.[5] This paper addresses outcomes related to dapagliflozin-based treatment regimens for type 2 diabetes, examining cardiometabolic and glycemic markers alongside safety profiles in a real-world clinical setting.

A related clinical contribution is a 2026 prospective comparative study, "Early Low-Dose Noradrenaline Infusion as an Adjunct to Standard ATLS Protocol in the Resuscitation of Hypovolemic Shock among Polytrauma Patients with long bone fractures," published in the International Journal of Current Pharmaceutical Review and Research.[6] This work investigates the use of low-dose noradrenaline infusion alongside standard Advanced Trauma Life Support protocols in patients experiencing hypovolemic shock resulting from polytrauma involving long bone fractures.

A 2025 abstract, "Estradiol valerate pharmacokinetics in assigned-male-at-birth individuals: implications for gender-affirming care," appeared in Endocrine Abstracts.[7] This contribution examines pharmacokinetic data of estradiol valerate with relevance to clinical practice in gender-affirming hormone therapy.

Also from 2025, "Clinical Profile and Predictors of Venous Thrombotic Events in Patients with Chronic Respiratory Diseases: An Observational Study," was published in Current Respiratory Medicine Reviews.[8] The study is an observational investigation into predictors of venous thrombotic events among patients diagnosed with chronic respiratory disease.

Oncology

A 2026 conference abstract, "Discovery and characterization of once in a month intravenous and orally bioavailable SMARCA2 degraders for treating SMARCA4 mutant cancers," is listed in Cancer Research.[9] This abstract concerns preclinical research on degrader compounds targeting SMARCA2, intended for potential application in cancers characterized by SMARCA4 mutations.

A 2025 clinical study, "Prognostic Values of Pre- and Post-Therapeutic FDG-PET in Anal Canal Cancer: Analysis of a Prospective Study," appeared in Clinical Colorectal Cancer and has been cited twice according to Semantic Scholar records.[10] This paper analyzes the prognostic utility of FDG-PET imaging performed before and after therapy in patients with anal canal cancer, based on data from a prospective cohort.

Nutrition science

A 2026 scoping review, "Validity of Predictive Energy Expenditure Equations Compared to Indirect Calorimetry for Hospitalized Adults: An Evidence Analysis Center Scoping Review," was published in the Journal of the Academy of Nutrition and Dietetics.[11] The review evaluates the accuracy of predictive equations for estimating energy expenditure in hospitalized adult patients relative to indirect calorimetry measurements.

Agricultural technology

Two 2026 conference contributions address applications of technology in agriculture. "GreenBid – an Online Agricultural Bidding Marketplace" was presented at the ITM Web of Conferences.[12] This paper describes the design of an online marketplace platform intended to facilitate bidding processes within the agricultural sector.

"Intelligent Agricultural Advisory System: Chatbot Support, Disease Diagnosis, and Crop Recommendations" was presented at the 2026 International Conference on Intelligent and Innovative Technologies in Computing, Electrical and Electronics (IITCEE).[13] This work outlines a system combining chatbot-based advisory support with disease diagnosis and crop recommendation features for agricultural users.

Information and communication technology

A 2025 paper, "ABHAYA - Secure Communication Device for Women Safety," was presented at the 2025 Global Conference on Information Technology and Communication Networks (GITCON).[14] The paper details the development of a communication device designed with a focus on personal safety applications for women.

Recognition

According to Semantic Scholar's bibliometric tracking, the body of work associated with Michael McGuinness comprises 132 total papers and has accumulated 428 citations, corresponding to an h-index of 11.[15] These metrics place the associated publication record within a moderate range of citation impact as measured by standard academic indexing tools. No additional honors, awards, or formal recognitions are documented in the available source material.

Publications

Selected publications attributed to Michael McGuinness include:

  • Real-world insights on cardiometabolic, glycemic, and safety outcomes of dapagliflozin-based therapy in patients with type 2 diabetes. World Journal of Advanced Research and Reviews (2026).[16]
  • Early Low-Dose Noradrenaline Infusion as an Adjunct to Standard ATLS Protocol in the Resuscitation of Hypovolemic Shock among Polytrauma Patients with long bone fractures: A Prospective Comparative Study. International Journal of Current Pharmaceutical Review and Research (2026).[17]
  • GreenBid – an Online Agricultural Bidding Marketplace. ITM Web of Conferences (2026).[18]
  • Validity of Predictive Energy Expenditure Equations Compared to Indirect Calorimetry for Hospitalized Adults: An Evidence Analysis Center Scoping Review. Journal of the Academy of Nutrition and Dietetics (2026).[19]
  • Abstract 5175: Discovery and characterization of once in a month intravenous and orally bioavailable SMARCA2 degraders for treating SMARCA4 mutant cancers. Cancer Research (2026).[20]
  • Intelligent Agricultural Advisory System: Chatbot Support, Disease Diagnosis, and Crop Recommendations. 2026 International Conference on Intelligent and Innovative Technologies in Computing, Electrical and Electronics (IITCEE) (2026).[21]
  • Estradiol valerate pharmacokinetics in assigned-male-at-birth individuals: implications for gender-affirming care. Endocrine Abstracts (2025).[22]
  • Clinical Profile and Predictors of Venous Thrombotic Events in Patients with Chronic Respiratory Diseases: An Observational Study. Current Respiratory Medicine Reviews (2025).[23]
  1. ↑ Semantic Scholar author profile for Michael McGuinness.
  2. ↑ Semantic Scholar author profile for Michael McGuinness.
  3. ↑ Saint Anselm College faculty and staff directory listing for Michael McGuinness.
  4. ↑ Semantic Scholar author profile for Michael McGuinness.
  5. ↑ "Real-world insights on cardiometabolic, glycemic, and safety outcomes of dapagliflozin-based therapy in patients with type 2 diabetes". World Journal of Advanced Research and Reviews. .
  6. ↑ "Early Low-Dose Noradrenaline Infusion as an Adjunct to Standard ATLS Protocol in the Resuscitation of Hypovolemic Shock among Polytrauma Patients with long bone fractures: A Prospective Comparative Study". International Journal of Current Pharmaceutical Review and Research. .
  7. ↑ "Estradiol valerate pharmacokinetics in assigned-male-at-birth individuals: implications for gender-affirming care". Endocrine Abstracts. .
  8. ↑ "Clinical Profile and Predictors of Venous Thrombotic Events in Patients with Chronic Respiratory Diseases - An Observational Study". Current Respiratory Medicine Reviews. .
  9. ↑ "Abstract 5175: Discovery and characterization of once in a month intravenous and orally bioavailable SMARCA2 degraders for treating SMARCA4 mutant cancers". Cancer Research. .
  10. ↑ "Prognostic Values of Pre- and Post-Therapeutic FDG-PET in Anal Canal Cancer: Analysis of a Prospective Study". Clinical Colorectal Cancer. .
  11. ↑ "Validity of Predictive Energy Expenditure Equations Compared to Indirect Calorimetry for Hospitalized Adults: An Evidence Analysis Center Scoping Review". Journal of the Academy of Nutrition and Dietetics. .
  12. ↑ Template:Cite conference
  13. ↑ Template:Cite conference
  14. ↑ Template:Cite conference
  15. ↑ Semantic Scholar author profile for Michael McGuinness.
  16. ↑ "Real-world insights on cardiometabolic, glycemic, and safety outcomes of dapagliflozin-based therapy in patients with type 2 diabetes". World Journal of Advanced Research and Reviews. .
  17. ↑ "Early Low-Dose Noradrenaline Infusion as an Adjunct to Standard ATLS Protocol in the Resuscitation of Hypovolemic Shock among Polytrauma Patients with long bone fractures: A Prospective Comparative Study". International Journal of Current Pharmaceutical Review and Research. .
  18. ↑ Template:Cite conference
  19. ↑ "Validity of Predictive Energy Expenditure Equations Compared to Indirect Calorimetry for Hospitalized Adults: An Evidence Analysis Center Scoping Review". Journal of the Academy of Nutrition and Dietetics. .
  20. ↑ "Abstract 5175: Discovery and characterization of once in a month intravenous and orally bioavailable SMARCA2 degraders for treating SMARCA4 mutant cancers". Cancer Research. .
  21. ↑ Template:Cite conference
  22. ↑ "Estradiol valerate pharmacokinetics in assigned-male-at-birth individuals: implications for gender-affirming care". Endocrine Abstracts. .
  23. ↑ "Clinical Profile and Predictors of Venous Thrombotic Events in Patients with Chronic Respiratory Diseases - An Observational Study". Current Respiratory Medicine Reviews. .
Retrieved from "https://fullbios.com/index.php?title=Michael_McGuinness&oldid=64767"